Gene: HMHB1
Official Full Name: histocompatibility minor HB-1provided by HGNC
Gene Summary: This gene encodes one of the minor histocompatibility antigens, which play an important role in the induction of cytotoxic T lymphocyte (CTL) reactivity against leukemia after human histocompatibility leukocyte antigen (HLA)-identical allogeneic bone marrow transplantation (BMT). This gene is only expressed in B cell acute lymphoblastic leukemia cells and Epstein-Barr virus-transformed B cells. The translation of this mRNA initiates at a non-AUG (CUG) codon. [provided by RefSeq, Jul 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA01776 | HMHB1 Knockout cell line (293T) | Human | HMHB1 | 1:3~1:6 | negative | Online Inquiry |
| KOA07886 | HMHB1 Knockout cell line (AC16) | Human | HMHB1 | 1:3-1:4 | negative | Online Inquiry |
| KOA23332 | HMHB1 Knockout cell line (BEAS-2B) | Human | HMHB1 | 1:3~1:4 | negative | Online Inquiry |
| KOA38780 | HMHB1 Knockout cell line (U-2932) | Human | HMHB1 | 1:2-1:4 | negative | Online Inquiry |
| KOA54174 | HMHB1 Knockout cell line (TPC-1) | Human | HMHB1 | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.